RxDoctor Payments Data

Levi Walker, MD

Internal Medicine · Pittsburgh, PANPI 1053484915

Payments from drug & device makers

$966in general payments, 2019–2025

Across 33 payments — averaging $29.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$181
  • Abbott$173
  • Sanofi$145
  • Merck$125
  • GSK$115
  • Lilly USA, LLC$73
  • plus $154 from 4 others

What the payments were for

  • Food & beverage$95198%
  • Education$152%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$966 in reported general payments places this provider in the 75th percentile of 5,705 internal medicine providers in Pennsylvania.

See all internal medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$17,872
Medicare patients
31
Services billed
232

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate60$63,994
TradjentaLinagliptin47$40,083
TrulicityDulaglutide27$31,588
OzempicSemaglutide28$29,845
XareltoRivaroxaban19$26,167
EliquisApixaban33$19,571
Morphine Sulfate ErMorphine Sulfate24$4,388
Atorvastatin Calcium277$3,744
Fluticasone-SalmeterolFluticasone Propion/Salmeterol23$3,421
Lantus SolostarInsulin Glargine,hum.Rec.Anlog40$3,221
Albuterol Sulfate HfaAlbuterol Sulfate95$3,188
Novolog FlexpenInsulin Aspart12$2,815
Omeprazole186$2,132
Amlodipine Besylate322$2,110
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen82$1,618

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia$125$63,99460 claims
Boehringer IngelheimTradjenta$69$40,08347 claims
Lilly USA, LLCTrulicity$73$31,58827 claims
PfizerEliquis$47$19,57133 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 5,705 internal medicine providers in Pennsylvania.

Other internal medicine in Pittsburgh

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →